← FDA Drug Approvals (Drugs@FDA)

PIRFENIDONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2022-08-01

Drug application

FDA Application #

ANDA212077

Application type

Abbreviated New Drug Application (Generic)

Brand name

PIRFENIDONE

Generic name

PIRFENIDONE

Active ingredients

PIRFENIDONE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

ScieGen Pharmaceuticals, Inc.

First approval

2022-08-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown